Cytosorbents corp (CTSO)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current Assets:
Cash and cash equivalents

26,389

12,232

15,977

16,341

19,647

22,368

24,911

25,282

21,089

17,321

15,400

16,402

3,239

5,245

6,375

8,670

3,537

5,316

7,385

8,017

10,418

3,605

433

4,878

6,416

2,183

2,349

1,870

1,365

1,729

2,061

1,741

1,803

1,186

2,296

3,416

1,055

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

249

2,490

2,192

1,943

3,188

2,939

1,944

7,346

4,745

4,745

0

-

-

-

-

-

-

-

-

-

-

-

Grants and accounts receivable, net of allowance for doubtful accounts of $149,841 at March 31, 2020 and $145,313 at December 31, 2019

5,395

4,467

3,447

3,450

3,267

3,943

3,642

2,902

2,352

2,205

2,350

2,058

1,732

1,433

1,406

944

760

648

553

-

-

819

-

-

-

-

-

-

-

-

-

-

39

-

-

-

-

Grants and accounts receivable, net of allowance for doubtful accounts of $3,728 at June 30, 2015 and $3,756 at December 31, 2014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

501

672

-

561

330

327

453

193

84

114

51

51

43

-

36

-

-

-

Inventories

1,967

2,113

1,768

1,462

1,213

833

779

769

680

795

1,089

889

857

833

1,051

1,047

1,059

1,190

1,337

1,059

702

537

387

303

146

245

362

476

555

682

625

535

468

431

186

-

-

Prepaid expenses and other current assets

3,777

2,088

1,156

959

700

1,118

617

1,825

393

415

546

390

451

315

219

161

194

511

372

274

148

700

225

364

193

605

737

155

94

476

116

146

47

43

33

35

344

Total current assets

37,529

20,901

22,350

22,214

24,828

28,264

29,950

30,780

24,515

20,739

19,386

19,741

6,281

7,828

9,052

11,073

8,041

9,860

11,591

13,040

14,881

7,607

8,954

10,622

11,827

3,486

3,644

2,586

2,129

2,939

2,855

2,466

2,358

1,697

2,516

3,452

1,400

Property and equipment, net

1,993

1,925

1,917

1,923

1,896

1,729

1,677

1,769

1,608

1,402

1,032

725

588

569

624

599

569

557

479

402

330

245

191

171

155

144

143

142

139

145

134

142

148

155

144

139

144

Right of use asset

970

1,070

1,169

1,265

1,359

1,449

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

3,733

3,484

3,244

3,079

2,910

2,753

2,622

2,395

2,179

1,961

1,799

1,620

1,419

1,296

1,180

1,037

901

836

731

655

652

615

481

462

409

414

251

251

257

254

278

287

277

269

273

271

267

Total long-term assets

-

-

-

-

-

-

-

-

-

-

2,832

2,345

2,008

-

-

-

1,470

-

-

-

982

861

672

634

565

558

394

394

397

399

413

429

425

425

418

410

411

Total Assets

44,226

27,382

28,682

28,482

30,994

34,196

34,249

34,945

28,303

24,103

22,218

22,086

8,289

9,693

10,857

12,711

9,512

11,254

12,802

14,098

15,864

8,468

9,626

11,257

12,393

4,045

4,039

2,981

2,526

3,339

3,268

2,896

2,784

2,122

2,934

3,862

1,811

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable

1,770

2,039

2,071

2,150

1,840

1,485

1,859

1,253

2,139

1,244

1,288

1,581

1,660

1,330

739

1,021

860

684

526

417

475

698

446

525

527

786

572

720

704

800

728

620

647

675

784

832

817

Current maturities of long-term debt

4,166

1,666

3,125

833

1,666

666

0

0

0

4,000

3,000

2,000

1,250

833

416

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability - current portion

442

428

413

399

388

378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

5,084

5,802

3,691

3,536

2,815

4,385

2,401

2,237

1,846

2,603

1,489

1,602

1,608

2,114

1,539

1,103

769

723

756

717

733

824

445

638

379

361

496

471

288

349

374

498

453

558

566

585

401

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

3

5

117

272

435

-

-

0

-

-

-

-

-

-

-

Warrant liability at fair value

-

-

-

-

-

-

-

-

-

-

-

1,046

1,664

-

2,302

1,808

1,617

1,636

2,163

1,392

4,989

2,981

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

654

889

546

0

-

-

-

-

-

-

-

-

-

-

-

Current portion of convertible notes payable, net of debt discount in the amount of $198,644 at December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

709

1,727

1,644

1,561

912

0

926

973

1,185

1,147

294

238

-

-

Total current liabilities

11,464

9,936

9,301

6,919

6,711

6,916

4,261

3,491

3,986

7,848

5,778

6,229

6,182

4,278

4,999

3,933

3,248

3,043

3,446

2,527

6,198

4,505

1,549

2,769

3,298

3,064

3,065

2,104

993

2,076

2,075

2,304

2,248

1,527

1,588

1,418

1,219

Long term debt, net of current maturities and debt issuance costs

10,921

13,385

11,891

9,155

8,298

9,274

9,917

9,893

9,869

5,992

6,966

7,940

3,676

4,078

4,479

4,881

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, net of current portion

527

642

755

865

970

1,070

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable, net of debt discount in the amount of -0- at December 31, 2012 and $508,750 at December 31, 2011

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

276

224

526

1,077

Total Long Term Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

276

224

526

1,077

Total Liabilities

22,912

23,964

21,948

16,940

15,979

17,262

14,178

13,384

13,856

13,840

12,744

14,170

9,859

8,356

9,479

8,814

-

3,043

-

-

-

-

-

-

-

-

3,065

2,104

993

2,076

2,075

2,304

2,248

1,804

1,813

1,945

2,296

Commitments and Contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

Redeemable Series B Convertible Preferred Stock, -0- and 200,000 shares authorized; -0- and 79,336.54 issued and outstanding at December 31, 2014 and 2013, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,874

17,717

16,353

15,246

14,583

14,062

13,470

12,887

-

-

-

-

-

-

-

Stockholders' Equity:
Preferred Stock, Par Value $0.001, 5,000,000 shares authorized; -0- shares issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

1

1

1

-

1

1

1

1

-

-

-

1

-

-

-

Common Stock, Par Value $0.001, 100,000,000 shares authorized; 36,130,355 and 32,616,107 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

36

32

32

32

32

31

31

31

29

28

28

28

25

25

25

25

25

25

25

24

24

23

322

310

299

10

245

234

228

214

209

199

189

177

172

165

122

Additional paid-in capital

212,383

191,648

190,385

189,120

188,795

186,138

184,089

182,674

170,402

162,907

158,734

154,690

143,479

143,929

140,980

140,755

140,261

140,126

139,408

138,727

138,180

128,106

102,713

101,631

100,390

91,584

90,587

89,574

88,795

86,903

98,535

96,663

94,991

82,288

91,575

89,914

83,375

Accumulated other comprehensive income

1,135

525

1,156

344

594

288

70

-29

-690

-360

-123

156

767

898

422

483

338

584

445

495

571

227

67

-50

-55

-55

24

-15

-15

-12

-

-

-

0

-

-

-

Accumulated deficit

-192,242

-188,789

-184,840

-177,955

-174,407

-169,523

-164,120

-161,115

-155,294

-152,312

-149,165

-146,959

-145,842

-143,516

-140,050

-137,367

-134,362

-132,525

-130,524

-127,676

-129,111

-124,394

-113,902

-

-

-105,805

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111,123

107,895

-

104,469

102,979

100,947

98,732

97,554

96,272

94,648

92,557

90,627

88,164

83,988

Total Stockholders' Equity

21,313

3,418

6,733

11,542

15,014

16,934

20,070

21,560

14,447

10,262

9,473

7,915

-1,570

1,337

1,378

3,896

6,263

8,210

9,355

11,570

9,665

3,963

-10,797

-9,230

-7,258

-14,265

-13,610

-13,185

-11,936

-11,625

1,192

591

535

-10,090

1,121

1,917

-484

Total Liabilities and Stockholders' Equity

44,226

27,382

28,682

28,482

30,994

34,196

34,249

34,945

28,303

24,103

22,218

22,086

8,289

9,693

10,857

12,711

9,512

11,254

12,802

14,098

15,864

8,468

9,626

11,257

12,393

4,045

4,039

2,981

2,526

3,339

3,268

2,896

2,784

2,122

2,934

3,862

1,811